Innovating Works

INSILICO

Desconocido
Inno4Vac: Innovations to accelerate vaccine development and manufacture INSILICO BIOTECHNOLOGY AG participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
GLIOTRAIN: Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational... INSILICO BIOTECHNOLOGY AG participó en un H2020: H2020-MSCA-ITN-2017 Glioblastoma (GBM) is the most frequent, aggressive and lethal of all brain tumours. It has a universally fatal prognosis with 85% of patien...
2017-08-29 - 2021-08-31 | Financiado
SynCrop: Synthetic Circuits for Robust Orthogonal Production INSILICO BIOTECHNOLOGY AG participó en un H2020: H2020-MSCA-ITN-2017 The repertoire of industrially produced fine chemicals in various biological systems will rapidly expand using the tools from the emerging f...
2017-08-10 - 2021-12-31 | Financiado
SyMBioSys: Systematic Models for Biological Systems Engineering Training Network INSILICO BIOTECHNOLOGY AG participó en un H2020: H2020-MSCA-ITN-2015 Mathematical, computational models are central in biomedical and biological systems engineering; models enable (i) mechanistically justifyin...
2015-08-11 - 2019-08-31 | Financiado
BIOPREDYN: From Data to Models New Bioinformatics Methods and Tools for Data Driven Predictive Dynamic Modelli... INSILICO BIOTECHNOLOGY AG participó en un FP7: Currently, biologists are collecting enormous amounts of ‘omics’ data in a vast number of different databases. Predictive, data-driven compu...
Financiado
COSMOS: Integrated In Silico Models for the Prediction of Human Repeated Dose Toxicity of Cosmetics to Optim... INSILICO BIOTECHNOLOGY AG participó en un FP7: The COSMOS project will address the assessment needs of the cosmetics industry by delivering an integrated suite of computational tools to p...
Financiado
NOTOX: Predicting long term toxic effects using computer models based on systems characterization of organo... INSILICO BIOTECHNOLOGY AG participó en un FP7: NOTOX will develop and establish a spectrum of systems biological tools including experimental and computational methods for i) organotypic...
Financiado
PROMYSE: Products from methanol by synthetic cell factories INSILICO BIOTECHNOLOGY AG participó en un FP7: There is a high societal need for a sustainable production of key chemistry, food and health care compounds. Microbial cell factories are lo...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.